
Novo Seeds returned for a series B round that will support the progress of NorthSea Therapeutics' lead liver disease candidate through clinical trials.
The eye disease drug developer has closed a round led by existing backer Boehringer Ingelheim Venture Fund to take its total funding above $42m.
Citi Ventures and Susquehanna Growth Equity both returned for the business accounting software provider’s series B round, which enabled it to achieve a unicorn valuation.
Trifo, developer of a cleaning-based surveillance system, increased its total funding to $26m in a round that included Yidu Cloud.
In an extended version covering the holidays, Global Corporate Venturing has rounded up the period’s smaller deals and tracked the emerging companies accessing corporate funds.
The Legend Capital-backed radiology-imaging technology provider received $23m in a series B round led by Sherpa Venture Capital.
Naver contributed to a series B round for the audio streaming service, which already counts SoftBank Ventures Asia among its backers.
Tencent, Parkway Global and returning investor Lilly Asia Ventures all contributed to a series B round that boosted the cancer immunotherapy developer's total funding to $155m.
CreditEase was among the investors in enterprise AI technology startup AInnovation's series B round, which was more than $57m in size.
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.